SonoLinq Terms and Conditions and Non-Solicit Agreement

BY ACCESSING, REGISTERING FOR, BROWSING, LOGGING INTO, USING, OR OTHERWISE PARTICIPATING IN THE SONOLINQ PLATFORM, USER AGREES TO BE LEGALLY BOUND BY THIS AGREEMENT. IF USER DOES NOT AGREE TO ALL TERMS OF THIS AGREEMENT, USER SHALL NOT ACCESS OR USE THE PLATFORM.

THIS AGREEMENT CONTAINS IMPORTANT PROVISIONS INCLUDING NON-SOLICITATION RESTRICTIONS, ANTI-CIRCUMVENTION RESTRICTIONS, CONFIDENTIALITY OBLIGATIONS, LIMITATIONS OF LIABILITY, MANDATORY ARBITRATION REQUIREMENTS, LIQUIDATED DAMAGES PROVISIONS, AND OTHER LEGALLY BINDING TERMS.

ARTICLE 1

DEFINITIONS

For purposes of this Agreement, the following terms shall have the meanings set forth below.

1.1 "SonoLinq"

"SonoLinq" means SonoLinq, its owners, members, managers, officers, directors, employees, agents, representatives, affiliates, successors, assigns, licensors, contractors, subsidiaries, parent entities, and all related business operations.

1.2 "Platform"

"Platform" means the SonoLinq website, mobile applications, software systems, databases, communication tools, scheduling tools, matching systems, workflows, algorithms, business processes, data systems, and all associated services.

1.3 "User"

"User" means any individual or entity that accesses, visits, views, browses, registers, creates an account, logs into, communicates through, receives information from, submits information to, or otherwise utilizes the Platform in any manner.

Users include, without limitation:

  • (a) Sonographers
  • (b) Clients
  • (c) Companies
  • (d) Facilities
  • (e) Healthcare practices
  • (f) Healthcare providers
  • (g) Physicians
  • (h) Managers
  • (i) Administrators
  • (j) Recruiters
  • (k) Contractors
  • (l) Any affiliated representative of the foregoing

1.4 "Active User"

An Active User includes any User who has, within the preceding twenty-four (24) months:

  • (a) Logged into the Platform
  • (b) Maintained an account
  • (c) Viewed assignments
  • (d) Posted assignments
  • (e) Searched opportunities
  • (f) Submitted opportunities
  • (g) Received communications
  • (h) Sent communications
  • (i) Received payment
  • (j) Submitted payment
  • (k) Accepted assignments
  • (l) Completed assignments
  • (m) Accessed user information
  • (n) Utilized any Platform feature

Active User status shall be determined solely by SonoLinq records.

1.5 "Protected Relationship"

A Protected Relationship means any relationship, contact, communication, introduction, referral, assignment, opportunity, interaction, business discussion, negotiation, or business connection that originates directly or indirectly from the Platform.

1.6 "Protected Introduction"

A Protected Introduction means any introduction, referral, connection, lead, contact, communication, recommendation, suggestion, opportunity, or business relationship first discovered, facilitated, identified, presented, communicated, introduced, or enabled through the Platform.

1.7 "Protected Opportunity"

A Protected Opportunity means any opportunity discovered, posted, communicated, viewed, accepted, discussed, negotiated, referred, routed, facilitated, expanded, renewed, extended, or otherwise made available through the Platform.

Protected Opportunities include future opportunities, repeat engagements, recurring work, expanded services, referrals, affiliate opportunities, successor opportunities, and derivative opportunities.

1.8 "Confidential Information"

Confidential Information includes:

  • (a) User identities
  • (b) Contact information
  • (c) Assignment information
  • (d) Pricing information
  • (e) Business practices
  • (f) Compensation information
  • (g) Proprietary workflows
  • (h) Matching methodologies
  • (i) Business intelligence
  • (j) Analytics
  • (k) Reports
  • (l) Platform data
  • (m) Opportunity data
  • (n) Introductions
  • (o) Referrals
  • (p) User activity information
  • (q) All non-public information made available through the Platform

ARTICLE 2

PLATFORM STATUS

2.1 Technology Marketplace Only

SonoLinq is solely a technology platform and business marketplace.

SonoLinq provides tools that facilitate communication, introductions, scheduling, opportunity discovery, and business coordination among independent parties.

SonoLinq does not provide healthcare services, diagnostic services, medical supervision, or patient care. SonoLinq does not employ sonographers, direct clinical decisions, or control the manner, means, methods, or performance of services performed by Users.

2.2 No Agency Relationship

No agency relationship is created between SonoLinq and any User. No User possesses authority to bind SonoLinq. No User may represent that they act on behalf of SonoLinq.

2.3 No Partnership

Nothing contained herein shall be construed as creating a partnership, joint venture, franchise, employment relationship, agency relationship, fiduciary relationship, or similar arrangement.

ARTICLE 3

INDEPENDENT CONTRACTOR ACKNOWLEDGEMENT

3.1 Independent Parties

All Users acknowledge that relationships established through the Platform are relationships between independent parties. SonoLinq is not a party to such relationships.

3.2 No Employment Relationship

Users acknowledge and agree that SonoLinq is not:

  • (a) Employer
  • (b) Co-employer
  • (c) Staffing agency
  • (d) Personnel provider
  • (e) Workforce manager
  • (f) Supervisor
  • (g) Principal
  • (h) Healthcare provider

No User shall claim employee status against SonoLinq.

3.3 User Responsibility

Users remain solely responsible for:

  • (a) Compensation arrangements
  • (b) Tax obligations
  • (c) Insurance obligations
  • (d) Licensing obligations
  • (e) Credentialing obligations
  • (f) Regulatory compliance
  • (g) Healthcare compliance
  • (h) Patient care
  • (i) Clinical decisions
  • (j) Business decisions

ARTICLE 4

ACKNOWLEDGEMENT OF PLATFORM VALUE

4.1 Platform Investment

User acknowledges that SonoLinq has invested substantial time, effort, expertise, technology, capital, marketing resources, operational resources, business resources, and proprietary development efforts into creating, maintaining, operating, and expanding the Platform.

4.2 Valuable Business Assets

User expressly acknowledges that the following constitute valuable proprietary business assets of SonoLinq:

  • (a) Introductions
  • (b) Relationships
  • (c) Referrals
  • (d) Assignments
  • (e) Opportunities
  • (f) Business intelligence
  • (g) Network effects
  • (h) User relationships
  • (i) Communication systems
  • (j) Marketplace infrastructure
  • (k) Proprietary workflows
  • (l) Matching systems
  • (m) Opportunity routing systems
  • (n) Data systems
  • (o) Platform-generated goodwill

4.3 Material Consideration

User acknowledges that access to the Platform, network, opportunities, introductions, and relationships constitutes substantial consideration supporting the restrictions contained within this Agreement.

ARTICLE 5

NO EXPECTATION OF DIRECT OWNERSHIP

5.1 No Ownership Rights

Users acknowledge and agree that participation in the Platform does not create ownership rights in:

  • (a) Introductions
  • (b) Relationships
  • (c) Referrals
  • (d) Assignments
  • (e) Opportunities
  • (f) Platform-generated business activity
  • (g) Platform-generated goodwill
  • (h) User data
  • (i) Opportunity data
  • (j) Network relationships

5.2 Continuing Platform Interest

SonoLinq retains a continuing and protectable business interest in all Protected Relationships, Protected Introductions, and Protected Opportunities facilitated through the Platform.

ARTICLE 6

CONFIDENTIALITY

6.1 Confidentiality Obligations

User shall maintain all Confidential Information in strict confidence and shall not directly or indirectly disclose, distribute, share, transfer, publish, exploit, or utilize Confidential Information except as expressly permitted through authorized Platform activity.

6.2 Network Protection

User acknowledges that User identities, introductions, opportunities, communications, business relationships, and referral paths constitute proprietary assets of SonoLinq and are subject to protection under this Agreement.

6.3 Continuing Obligations

Confidentiality obligations survive termination of Platform access and remain in effect indefinitely unless otherwise prohibited by applicable law.

ARTICLE 7

PROTECTED RELATIONSHIPS, INTRODUCTIONS, AND OPPORTUNITIES

7.1 Protected Relationships

All Protected Relationships shall remain subject to the protections of this Agreement.

7.2 Protected Introductions

Any introduction first occurring through the Platform shall remain protected regardless of whether the parties ultimately engage in business.

7.3 Protected Opportunities

Any opportunity identified, viewed, discussed, communicated, routed, referred, accepted, negotiated, or facilitated through the Platform shall remain protected under this Agreement.

7.4 Expansion Protection

Protection extends to:

  • (a) Renewals
  • (b) Extensions
  • (c) Repeat engagements
  • (d) Future engagements
  • (e) Affiliate opportunities
  • (f) Subsidiary opportunities
  • (g) Parent-company opportunities
  • (h) Common-ownership opportunities
  • (i) Referral opportunities
  • (j) Successor opportunities
  • (k) Derivative opportunities

7.5 Circumvention Presumption

Where a Protected Relationship, Protected Introduction, or Protected Opportunity exists, any direct or indirect business arrangement occurring outside the Platform shall be presumed to have originated from Platform activity unless proven otherwise by clear and convincing evidence.

ARTICLE 8

NON-SOLICITATION

8.1 General Restriction

User shall not, directly or indirectly, solicit, recruit, encourage, induce, persuade, divert, hire, engage, contract with, refer to, communicate with for off-platform business purposes, or otherwise attempt to establish business relationships outside of the Platform with any Protected Relationship, Protected Introduction, or Protected Opportunity.

8.2 Active User Restriction

For so long as User remains an Active User, User shall not directly or indirectly engage in any activity intended to bypass, avoid, circumvent, replace, diminish, or interfere with SonoLinq's role in facilitating business relationships and opportunities.

8.3 Indirect Solicitation Prohibited

Indirect solicitation is prohibited and includes, without limitation:

  • (a) Solicitation through agents
  • (b) Solicitation through affiliates
  • (c) Solicitation through employees
  • (d) Solicitation through contractors
  • (e) Solicitation through recruiters
  • (f) Solicitation through staffing agencies
  • (g) Solicitation through family members
  • (h) Solicitation through business partners
  • (i) Solicitation through commonly owned entities
  • (j) Solicitation through successor entities

8.4 Mutual Restriction

The restrictions contained herein apply equally to:

  • (a) Sonographers
  • (b) Clients
  • (c) Companies
  • (d) Facilities
  • (e) Physicians
  • (f) Healthcare providers
  • (g) Managers
  • (h) Administrators
  • (i) Representatives
  • (j) Affiliates and related entities

ARTICLE 9

ANTI-CIRCUMVENTION

9.1 Prohibited Conduct

User shall not directly or indirectly circumvent, bypass, avoid, replace, interfere with, or otherwise attempt to avoid the Platform for the purpose of conducting business with any Protected Relationship, Protected Introduction, or Protected Opportunity.

9.2 Circumvention Includes

Circumvention includes, without limitation:

  • (a) Direct contracting outside the Platform
  • (b) Independent contractor agreements outside the Platform
  • (c) Employment arrangements outside the Platform
  • (d) Referral arrangements outside the Platform
  • (e) Verbal agreements outside the Platform
  • (f) Informal work arrangements
  • (g) Affiliate transactions
  • (h) Subsidiary transactions
  • (i) Parent company transactions
  • (j) Successor entity transactions
  • (k) Shell company transactions
  • (l) Third-party facilitated transactions
  • (m) Staffing agency arrangements
  • (n) Revenue-sharing arrangements
  • (o) Barter arrangements
  • (p) Any arrangement designed to avoid Platform fees or participation

9.3 No Avoidance Through Affiliated Parties

User shall not avoid the restrictions of this Agreement through:

  • (a) Parent entities
  • (b) Subsidiaries
  • (c) Sister companies
  • (d) Common ownership groups
  • (e) Related facilities
  • (f) Related physician groups
  • (g) Management companies
  • (h) Holding companies
  • (i) Successor organizations

ARTICLE 10

PROTECTED NETWORK RELATIONSHIPS

10.1 Scope

Protection applies to all relationships originating from the Platform.

10.2 Expanded Relationships

Protection extends to:

  • (a) Existing opportunities
  • (b) Future opportunities
  • (c) Repeat opportunities
  • (d) Expanded opportunities
  • (e) Related opportunities
  • (f) Affiliate opportunities
  • (g) Referral opportunities
  • (h) Introduced opportunities
  • (i) Derived opportunities

10.3 Introduced Parties

Where a User introduces another individual or entity to a Protected Relationship, such introduced party shall also be deemed a Protected Relationship.

ARTICLE 11

TWO-YEAR TAIL RESTRICTION

11.1 Tail Period

Upon cessation of Active User status, User shall remain bound by all Non-Solicitation and Anti-Circumvention provisions for twenty-four (24) months.

11.2 Restart of Restriction Period

The twenty-four (24) month period shall restart upon:

  • (a) New Platform activity
  • (b) New communications through the Platform
  • (c) New assignments
  • (d) New opportunities
  • (e) New introductions
  • (f) New referrals

11.3 Most Recent Interaction Controls

The restriction period shall be measured from the most recent Platform-related interaction involving the applicable Protected Relationship, Protected Introduction, or Protected Opportunity.

ARTICLE 12

BUYOUT OPTION

12.1 Limited Exception

SonoLinq may, in its sole and absolute discretion, authorize direct engagement between Users through a written buyout agreement.

12.2 No Automatic Right

No User possesses any right to a buyout. Approval remains solely within the discretion of SonoLinq.

12.3 Buyout Amount

Unless otherwise approved in writing, the buyout amount shall be the greater of:

  • (a) Twenty-Five Thousand Dollars ($25,000.00); or
  • (b) Twelve (12) months of projected Platform fees reasonably estimated by SonoLinq

12.4 Written Approval Required

No buyout shall be effective unless approved in writing by an authorized representative of SonoLinq.

ARTICLE 13

LIQUIDATED DAMAGES

13.1 Acknowledgement

The parties acknowledge that violations of this Agreement would cause substantial harm to SonoLinq, including harm that would be difficult or impossible to calculate with precision.

13.2 Liquidated Damages

In the event of a violation, User agrees to pay liquidated damages equal to the greater of:

  • (a) Fifty Thousand Dollars ($50,000.00) per violation
  • (b) Three (3) times all Platform fees avoided
  • (c) Actual damages incurred by SonoLinq

13.3 Not Exclusive Remedy

Liquidated damages shall be cumulative and shall not limit any other available remedy.

ARTICLE 14

TAIL REVENUE RECOVERY

14.1 Revenue Recovery

In addition to all other remedies, SonoLinq shall be entitled to recover revenue associated with any prohibited off-platform relationship.

14.2 Recoverable Amounts

Recoverable amounts include:

  • (a) Fees avoided
  • (b) Commissions avoided
  • (c) Revenue generated from prohibited relationships
  • (d) Revenue generated from derivative opportunities
  • (e) Revenue generated from referrals
  • (f) Revenue generated from affiliated entities

14.3 Continuing Recovery

Revenue recovery rights shall continue throughout the applicable restricted period.

ARTICLE 15

JOINT AND SEVERAL LIABILITY

15.1 Shared Responsibility

Where multiple parties knowingly participate in a violation of this Agreement, all participating parties shall be jointly and severally liable.

15.2 Full Recovery

SonoLinq may recover the full amount of damages, fees, costs, and remedies from any one or more responsible parties.

ARTICLE 16

ATTORNEY FEES AND INVESTIGATION COSTS

16.1 Attorney Fees

SonoLinq shall be entitled to recover all reasonable attorney fees, expert fees, consultant fees, arbitration fees, court costs, and collection expenses incurred in enforcing this Agreement.

16.2 Investigation Costs

SonoLinq shall be entitled to recover all reasonable costs incurred investigating suspected violations.

ARTICLE 17

INJUNCTIVE RELIEF

17.1 Irreparable Harm

User acknowledges that violations of this Agreement would cause immediate and irreparable harm.

17.2 Injunction Rights

SonoLinq shall be entitled to temporary, preliminary, and permanent injunctive relief without the necessity of posting bond.

17.3 Cumulative Remedies

Injunctive relief shall be in addition to all other available remedies.

ARTICLE 18

DIGITAL EVIDENCE

18.1 Admissibility

User agrees that Platform records may be used as evidence in arbitration, litigation, or other proceedings.

18.2 Evidence Includes

  • (a) Login records
  • (b) IP logs
  • (c) Communications
  • (d) Messages
  • (e) Assignment records
  • (f) Payment records
  • (g) Audit logs
  • (h) User activity logs
  • (i) Metadata
  • (j) Electronic acknowledgements

18.3 Reliability

User acknowledges the reliability and admissibility of electronically maintained business records generated by the Platform.

ARTICLE 19

LIMITATION OF LIABILITY

19.1 Platform Function

SonoLinq functions solely as a technology platform and marketplace designed to facilitate introductions, communications, scheduling, opportunity discovery, and business coordination among independent parties.

19.2 No Responsibility for User Conduct

SonoLinq shall not be responsible or liable for the acts, omissions, conduct, negligence, gross negligence, recklessness, malpractice, misconduct, errors, representations, warranties, contractual obligations, regulatory violations, licensing deficiencies, credential deficiencies, business practices, payment practices, employment practices, healthcare practices, patient interactions, or other actions of any User.

19.3 No Liability for Business Relationships

SonoLinq shall not be responsible for disputes arising from:

  • (a) Compensation disputes
  • (b) Billing disputes
  • (c) Payment disputes
  • (d) Employment disputes
  • (e) Independent contractor disputes
  • (f) Scheduling disputes
  • (g) Cancellation disputes
  • (h) Service quality disputes
  • (i) Professional conduct disputes
  • (j) Patient complaints
  • (k) Clinical outcomes
  • (l) Regulatory matters
  • (m) Tax matters
  • (n) Insurance matters
  • (o) Credentialing matters
  • (p) Licensing matters

19.4 No Consequential Damages

To the fullest extent permitted by law, SonoLinq shall not be liable for any:

  • (a) Lost profits
  • (b) Lost revenue
  • (c) Lost business opportunities
  • (d) Loss of goodwill
  • (e) Business interruption
  • (f) Indirect damages
  • (g) Incidental damages
  • (h) Consequential damages
  • (i) Special damages
  • (j) Punitive damages
  • (k) Exemplary damages

19.5 Maximum Liability

To the fullest extent permitted by law, SonoLinq's aggregate liability arising from or relating to the Platform shall not exceed the greater of:

  • (a) One Thousand Dollars ($1,000.00); or
  • (b) The total fees actually paid by the claimant to SonoLinq during the six (6) months immediately preceding the event giving rise to the claim

ARTICLE 20

NO WARRANTIES

20.1 Platform Provided "As Is"

The Platform is provided on an "AS IS," "AS AVAILABLE," and "WITH ALL FAULTS" basis.

20.2 Disclaimer of Warranties

SonoLinq expressly disclaims all warranties, whether express, implied, statutory, or otherwise, including:

  • (a) Merchantability
  • (b) Fitness for a particular purpose
  • (c) Non-infringement
  • (d) Accuracy
  • (e) Reliability
  • (f) Availability
  • (g) Performance
  • (h) Security

20.3 No Guarantee of Opportunities

SonoLinq does not guarantee:

  • (a) Assignments
  • (b) Coverage requests
  • (c) Revenue
  • (d) Business opportunities
  • (e) Client engagement
  • (f) Sonographer engagement
  • (g) Platform activity
  • (h) User participation

ARTICLE 21

HEALTHCARE SERVICES DISCLAIMER

21.1 No Medical Services

SonoLinq does not provide healthcare services, medical services, diagnostic services, treatment services, or patient care services.

21.2 No Clinical Supervision

SonoLinq does not supervise, direct, evaluate, manage, control, or oversee clinical services performed by Users.

21.3 Clinical Responsibility

All responsibility for patient care, medical judgment, diagnostic interpretation, healthcare compliance, and clinical outcomes remains solely with the applicable healthcare professionals and healthcare organizations.

ARTICLE 22

CREDENTIALS, LICENSING, AND VERIFICATION DISCLAIMER

22.1 User Responsibility

Users are solely responsible for maintaining all licenses, certifications, registrations, credentials, permits, insurance policies, and regulatory approvals required for their activities.

22.2 No Guarantee of Accuracy

Although SonoLinq may collect, display, store, review, or verify information, SonoLinq does not guarantee:

  • (a) Accuracy
  • (b) Authenticity
  • (c) Completeness
  • (d) Current status
  • (e) Regulatory standing
  • (f) Professional competence
  • (g) Fitness for any purpose

22.3 Independent Verification

Users are solely responsible for independently verifying the qualifications of other Users.

ARTICLE 23

INSURANCE REQUIREMENTS

23.1 User Obligation

Users shall maintain all insurance required by applicable law and industry standards.

23.2 No Insurance Provided

SonoLinq does not provide malpractice insurance, professional liability insurance, workers' compensation insurance, general liability insurance, cyber insurance, employment practices insurance, or any other insurance coverage for Users.

23.3 Proof of Coverage

SonoLinq may request proof of insurance at any time. Failure to provide requested documentation may result in suspension or termination.

ARTICLE 24

REGULATORY COMPLIANCE

24.1 User Responsibility

Users are solely responsible for compliance with:

  • (a) Federal laws
  • (b) State laws
  • (c) Local laws
  • (d) Healthcare regulations
  • (e) Privacy regulations
  • (f) Employment regulations
  • (g) Independent contractor regulations
  • (h) Tax regulations
  • (i) Licensing requirements

24.2 HIPAA Compliance

Users remain solely responsible for HIPAA compliance and the protection of protected health information.

ARTICLE 25

INDEMNIFICATION

25.1 Indemnification Obligation

User shall defend, indemnify, and hold harmless SonoLinq from and against any and all claims, demands, actions, proceedings, damages, liabilities, losses, costs, penalties, judgments, settlements, fines, attorney fees, and expenses arising from or related to:

  • (a) User conduct
  • (b) User negligence
  • (c) User regulatory violations
  • (d) User contractual obligations
  • (e) User healthcare activities
  • (f) User employment activities
  • (g) User tax obligations
  • (h) User insurance obligations
  • (i) User breach of this Agreement

25.2 Continuing Obligation

Indemnification obligations shall survive termination of this Agreement.

ARTICLE 26

NON-DISPARAGEMENT

26.1 Restriction

Users shall not knowingly make false, misleading, defamatory, malicious, or materially inaccurate statements concerning SonoLinq.

26.2 Protected Rights

Nothing herein shall prohibit truthful statements required by law or participation in legally protected activities.

ARTICLE 27

FORCE MAJEURE

27.1 Excused Performance

SonoLinq shall not be liable for delays, interruptions, failures, or inability to perform resulting from events beyond its reasonable control.

27.2 Covered Events

Covered events include:

  • (a) Natural disasters
  • (b) Severe weather
  • (c) Power outages
  • (d) Cyberattacks
  • (e) Internet outages
  • (f) Government actions
  • (g) Labor disruptions
  • (h) Pandemics
  • (i) Public emergencies

ARTICLE 28

MANDATORY BINDING ARBITRATION

28.1 Arbitration Required

Except as otherwise provided herein, all disputes arising from or relating to this Agreement shall be resolved exclusively through binding arbitration.

28.2 Arbitration Rules

Arbitration shall be administered under the commercial arbitration rules then in effect.

28.3 Venue

Arbitration shall occur in the State of Texas unless otherwise agreed in writing.

28.4 Waiver of Jury Trial

The parties knowingly and voluntarily waive any right to trial by jury.

28.5 Class Action Waiver

Users waive any right to participate in class actions, collective actions, or representative actions against SonoLinq.

ARTICLE 29

GOVERNING LAW

29.1 Texas Law

This Agreement shall be governed by and construed under the laws of the State of Texas, without regard to conflict-of-law principles.

ARTICLE 30

EQUITABLE RELIEF

30.1 Court Access

Notwithstanding the arbitration provisions herein, SonoLinq may seek temporary, preliminary, or permanent injunctive relief in any court of competent jurisdiction.

30.2 Purpose

This provision applies particularly to violations involving:

  • (a) Confidential Information
  • (b) Proprietary Information
  • (c) Non-Solicitation
  • (d) Anti-Circumvention
  • (e) Protected Relationships
  • (f) Protected Introductions
  • (g) Protected Opportunities

ARTICLE 31

ELECTRONIC SIGNATURES

31.1 Electronic Acceptance

User agrees that electronic acceptance of this Agreement constitutes a legally binding signature.

31.2 Binding Effect

Electronic records, electronic acknowledgements, electronic clicks, electronic confirmations, and electronic acceptance logs shall have the same force and effect as handwritten signatures.

ARTICLE 32

SUCCESSORS AND ASSIGNS

32.1 Binding Effect

This Agreement shall be binding upon and inure to the benefit of the parties and their successors, assigns, heirs, representatives, affiliates, subsidiaries, parent entities, and permitted transferees.

32.2 Transfer Rights

SonoLinq may assign or transfer this Agreement without User consent in connection with a merger, acquisition, restructuring, sale, financing transaction, or transfer of business assets.

ARTICLE 33

SEVERABILITY

33.1 Partial Invalidity

If any provision of this Agreement is determined to be invalid or unenforceable, the remaining provisions shall remain in full force and effect.

33.2 Judicial Modification

Any unenforceable provision shall be modified to the maximum extent permitted by applicable law in order to effectuate the parties' intent.

ARTICLE 34

SURVIVAL

34.1 Continuing Obligations

The following provisions shall survive termination of Platform access, account closure, inactivity, suspension, or expiration:

  • (a) Confidentiality
  • (b) Proprietary Information
  • (c) Protected Relationships
  • (d) Protected Introductions
  • (e) Protected Opportunities
  • (f) Non-Solicitation
  • (g) Anti-Circumvention
  • (h) Tail Restrictions
  • (i) Buyout Rights
  • (j) Revenue Recovery
  • (k) Indemnification
  • (l) Arbitration
  • (m) Attorney Fees
  • (n) Investigation Costs
  • (o) Equitable Relief

ARTICLE 35

ENTIRE AGREEMENT

35.1 Entire Agreement

This Agreement constitutes the entire agreement between the parties regarding the subject matter herein and supersedes all prior discussions, understandings, negotiations, representations, and agreements.

35.2 Amendments

SonoLinq may modify this Agreement from time to time by publishing updated terms through the Platform. Continued use of the Platform following such publication constitutes acceptance of the revised terms.

ARTICLE 36

ACKNOWLEDGEMENT

BY ACCESSING OR USING THE PLATFORM, USER ACKNOWLEDGES THAT USER HAS READ, UNDERSTOOD, AND AGREES TO BE LEGALLY BOUND BY THIS AGREEMENT.

USER FURTHER ACKNOWLEDGES THAT THE RESTRICTIONS CONTAINED HEREIN ARE REASONABLE, NECESSARY TO PROTECT SONOLINQ'S LEGITIMATE BUSINESS INTERESTS, AND MATERIAL TO SONOLINQ'S DECISION TO PROVIDE ACCESS TO THE PLATFORM.

SONOLINQ FOUNDER PROTECTION ADDENDUM

VERSION 1.0

ARTICLE 37

NO PLATFORM FEE AVOIDANCE

37.1 Fee Avoidance Prohibited

Users shall not structure, modify, divide, bundle, rebundle, redirect, delay, accelerate, conceal, or otherwise manipulate transactions for the purpose of reducing, avoiding, circumventing, or eliminating fees that would otherwise be payable to SonoLinq.

37.2 Artificial Transaction Structures

The creation of multiple agreements, separate invoices, separate entities, separate facilities, separate contractors, separate engagements, or similar arrangements intended to avoid Platform fees shall constitute circumvention.

ARTICLE 38

AUDIT RIGHTS

38.1 Audit Authority

Where SonoLinq reasonably suspects a violation of this Agreement, SonoLinq may request documentation reasonably necessary to investigate the matter.

38.2 Documentation

Documentation may include:

  • (a) Contracts
  • (b) Invoices
  • (c) Payment records
  • (d) Assignment records
  • (e) Communications
  • (f) Business records
  • (g) Related transaction records

38.3 Adverse Inference

Refusal to cooperate with a reasonable investigation may be considered evidence supporting the existence of a violation.

ARTICLE 39

ACCOUNT TERMINATION

39.1 Immediate Suspension

SonoLinq may suspend or terminate any account at any time where SonoLinq reasonably believes:

  • (a) Circumvention has occurred
  • (b) Solicitation has occurred
  • (c) Fraud has occurred
  • (d) Misrepresentation has occurred
  • (e) Regulatory concerns exist
  • (f) Platform integrity is threatened

39.2 No Refund Obligation

Unless prohibited by law, suspension or termination resulting from a User violation shall not create any refund obligation.

ARTICLE 40

NO EXPECTATION OF FUTURE ACCESS

40.1 Platform Access

Access to the Platform is a revocable privilege and not a right.

40.2 No Reliance

Users shall not rely upon continued Platform availability, continued access to opportunities, continued access to Users, or continued access to business relationships.

ARTICLE 41

NON-INTERFERENCE

41.1 Platform Relationships

Users shall not intentionally interfere with relationships between SonoLinq and any:

  • (a) User
  • (b) Client
  • (c) Sonographer
  • (d) Company
  • (e) Facility
  • (f) Vendor
  • (g) Business partner

41.2 Interference Prohibited

Interference includes encouraging others to:

  • (a) Leave the Platform
  • (b) Avoid the Platform
  • (c) Circumvent the Platform
  • (d) Breach Platform agreements

ARTICLE 42

NO DATA EXTRACTION

42.1 Data Mining Prohibited

Users shall not scrape, harvest, collect, extract, copy, reproduce, compile, aggregate, sell, distribute, or exploit Platform data.

42.2 User Lists

User directories, user identities, contact information, assignment information, pricing information, and opportunity information constitute proprietary Platform assets.

ARTICLE 43

NO COMPETING DATABASE CREATION

43.1 Competitive Use

Users shall not use Platform information to create, build, expand, train, populate, enhance, support, or operate a competing network, marketplace, staffing platform, referral platform, scheduling platform, database, or similar business.

43.2 Surviving Restriction

This restriction survives termination of Platform access.

ARTICLE 44

PLATFORM GOODWILL

44.1 Ownership

All goodwill arising from Platform activity shall belong exclusively to SonoLinq.

44.2 No Ownership Claim

Users waive any claim of ownership to goodwill generated through Platform relationships, introductions, referrals, assignments, or opportunities.

ARTICLE 45

DISCOVERY RULE

45.1 Delayed Discovery

Any limitation period relating to violations of this Agreement shall begin when SonoLinq discovers, or reasonably should have discovered, the violation.

45.2 Concealed Violations

Concealment, misrepresentation, fraud, or deceptive conduct shall toll any applicable limitation period to the fullest extent permitted by law.

ARTICLE 46

CUMULATIVE REMEDIES

46.1 Multiple Remedies

All remedies provided by this Agreement are cumulative.

46.2 No Election Required

SonoLinq may pursue one or more remedies simultaneously, consecutively, or independently.

ARTICLE 47

BUSINESS NECESSITY ACKNOWLEDGEMENT

47.1 Reasonableness

User acknowledges that the restrictions contained herein are reasonable in scope, duration, geography, and purpose.

47.2 Legitimate Interests

User acknowledges that the restrictions are necessary to protect:

  • (a) Proprietary information
  • (b) Confidential information
  • (c) Platform goodwill
  • (d) Business relationships
  • (e) Introductions
  • (f) Referrals
  • (g) Opportunities
  • (h) Network value
  • (i) Marketplace integrity

ARTICLE 48

CONSTRUCTION

48.1 Neutral Construction

This Agreement shall not be construed against SonoLinq based upon authorship.

48.2 Maximum Enforcement

All provisions shall be interpreted to provide the maximum lawful protection available under applicable law.

ARTICLE 49

USER CERTIFICATION

By using the Platform, User certifies and represents that:

  • (a) User has authority to enter this Agreement
  • (b) User has read this Agreement
  • (c) User understands this Agreement
  • (d) User voluntarily accepts this Agreement
  • (e) User intends to be legally bound by this Agreement
  • (f) User understands the non-solicitation and anti-circumvention provisions
  • (g) User understands the damages and enforcement provisions

SONOLINQ AGREEMENT v1.1

SUPPLEMENTAL HARDENING ADDENDUM

ARTICLE 50

COMMUNICATION MONITORING, STORAGE, AND CONSENT

50.1 User Consent

User expressly consents to SonoLinq storing, processing, reviewing, auditing, preserving, and utilizing communications occurring through the Platform.

50.2 Business Purpose

Such communications may be utilized for:

  • (a) Compliance purposes
  • (b) Fraud prevention
  • (c) Platform security
  • (d) Quality assurance
  • (e) User support
  • (f) Enforcement of this Agreement
  • (g) Investigation of violations
  • (h) Dispute resolution
  • (i) Legal proceedings

50.3 No Expectation of Privacy

Users acknowledge that communications transmitted through the Platform may be monitored, reviewed, retained, and produced in connection with enforcement activities and legal proceedings.

ARTICLE 51

SURVIVAL OF LIABILITY AFTER ACCOUNT DELETION

51.1 Continuing Obligations

Deletion, suspension, abandonment, expiration, inactivity, or termination of an account shall not release any User from obligations arising under this Agreement.

51.2 Continuing Enforcement

SonoLinq retains all enforcement rights following account deletion or termination.

ARTICLE 52

EXPANDED AFFILIATE, OWNERSHIP GROUP, AND RELATED ENTITY PROTECTION

52.1 Related Entities

Protected Relationships include:

  • (a) Parent entities
  • (b) Subsidiaries
  • (c) Sister companies
  • (d) Commonly owned organizations
  • (e) Related facilities
  • (f) Affiliated practices
  • (g) Management organizations
  • (h) Holding companies
  • (i) Future acquisitions
  • (j) Successor entities

52.2 Broad Interpretation

This provision shall be interpreted broadly to prevent circumvention through ownership structures or affiliated organizations.

ARTICLE 53

REVERSE SOLICITATION PROHIBITION

53.1 No Defense

It shall not constitute a defense that another party initiated contact.

53.2 Participation Constitutes Violation

Knowingly participating in a prohibited off-platform relationship constitutes a violation regardless of which party initiated communication or solicitation.

ARTICLE 54

BURDEN SHIFTING AND PLATFORM ORIGINATION PRESUMPTION

54.1 Presumption

Where a Protected Relationship, Protected Introduction, or Protected Opportunity exists, any subsequent off-platform engagement shall be presumed to have originated through the Platform.

54.2 User Burden

The burden shall shift to the participating parties to establish by clear and convincing evidence that the relationship did not originate through the Platform.

54.3 Evidence

SonoLinq may rely upon:

  • (a) Platform records
  • (b) Communication records
  • (c) User activity records
  • (d) Assignment history
  • (e) Payment records
  • (f) Audit logs
  • (g) Metadata

ARTICLE 55

REVENUE DISCLOSURE OBLIGATION

55.1 Disclosure Requirement

Upon reasonable request related to an alleged violation, User shall provide information reasonably necessary to calculate damages.

55.2 Required Records

Records may include:

  • (a) Contracts
  • (b) Invoices
  • (c) Payment records
  • (d) Tax documents
  • (e) Engagement records
  • (f) Revenue reports
  • (g) Related business records

55.3 Failure to Produce

Failure to provide requested records may permit damages to be estimated based upon available evidence and reasonable assumptions.

ARTICLE 56

NO WAIVER

56.1 Preservation of Rights

Failure by SonoLinq to enforce any provision shall not constitute a waiver.

56.2 Partial Enforcement

Enforcement of one provision shall not limit enforcement of any other provision.

56.3 Continuing Rights

All rights and remedies remain available unless expressly waived in a written instrument signed by an authorized representative of SonoLinq.

ARTICLE 57

PATIENT CARE SEPARATION

57.1 No Clinical Participation

SonoLinq does not diagnose, treat, supervise, interpret, review, manage, direct, or participate in patient care.

57.2 No Medical Judgment

SonoLinq does not exercise medical judgment and shall not be responsible for medical decisions, diagnostic conclusions, treatment recommendations, or clinical outcomes.

57.3 Sole Responsibility

All patient care responsibility remains solely with the healthcare professionals and healthcare organizations involved.

ARTICLE 58

PLATFORM DATA OWNERSHIP

58.1 Platform Property

SonoLinq owns all right, title, and interest in Platform-generated data, including:

  • (a) Analytics
  • (b) Marketplace metrics
  • (c) Matching data
  • (d) Routing data
  • (e) User activity data
  • (f) Opportunity data
  • (g) Business intelligence
  • (h) Performance metrics
  • (i) Platform reports

58.2 No Ownership Rights

Users acquire no ownership interest in Platform-generated data through use of the Platform.

ARTICLE 59

ACQUISITION, MERGER, AND SUCCESSOR PROTECTION

59.1 Automatic Transfer

All rights, protections, restrictions, remedies, obligations, and benefits contained in this Agreement shall automatically transfer to any successor entity.

59.2 Covered Transactions

Covered transactions include:

  • (a) Asset sales
  • (b) Stock sales
  • (c) Mergers
  • (d) Acquisitions
  • (e) Reorganizations
  • (f) Consolidations
  • (g) Financing transactions
  • (h) Business transfers

59.3 Continuing Effect

This Agreement shall remain fully enforceable following any such transaction.

ARTICLE 60

FINAL ACKNOWLEDGEMENT

60.1 Material Terms

User acknowledges that the non-solicitation, anti-circumvention, confidentiality, protected relationship, protected introduction, protected opportunity, buyout, revenue recovery, and enforcement provisions are material terms of this Agreement.

60.2 Access Consideration

User acknowledges that access to the Platform, opportunities, introductions, relationships, communications systems, and marketplace infrastructure constitutes substantial consideration supporting the restrictions contained herein.

60.3 Intent

User acknowledges that the intent of this Agreement is to protect SonoLinq's legitimate business interests, proprietary marketplace, network value, goodwill, business relationships, and platform-generated opportunities.

SONOLINQ AGREEMENT v1.1 — All rights reserved.